U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. FDA Organization
  4. Office of the Commissioner
  5. Office of Digital Transformation
  6. Joseph Montgomery
  1. Office of Digital Transformation

Joseph Montgomery
Leadership Role
OIMT/Office of Enterprise Portfolio Management Director - Office of Digital Transformation

Joseph Montgomery - OIMT/Office of Enterprise Portfolio Management
Joseph Montgomery

Joseph Montgomery is the Director of the Office of Enterprise Portfolio Management. In this role, he provides oversight for the Office of Digital Transformation’s (ODT) IT portfolio, IT Governance, Finance, Acquisition, and Enterprise Licenses functions. His office’s focus is on modernizing the FDA’s IT investments and portfolio of services to alignment with enterprise transformation, resource management, and enterprise cost-savings.

Mr. Montgomery has over 28 years of experience in the IT field and has been with FDA for over 25 years. Prior to his time in ODT, Joseph served as the Director of Bioinformatics and the Associate Deputy, Chief Information Officer for Center for Biologics Evaluation and Research.

He has managed many exciting programs at FDA which produced the first electronic submissions in CBER, developed international regulatory electronic submission standards, and established the Portfolio Management Office in OIMT. Joseph has received many certifications, awards and citations but is most proud of the dedicated and talented individuals that he has had the opportunity to work with to support the FDA mission.

“My father was a great inspiration to me. He demonstrated that dedication and hard work can overcome many obstacles.”

Back to Top